Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 106 | 100 | −6 |
| Shares | 63.8M | 50.9M | −12.9M (−20.3%) |
| Value | $475.8M | $276.0M | −$199.8M (−42.0%) |
New holders (19)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 852,300 | $4.64M | 0.01% |
| Sio Capital Management, LLC | 800,000 | $4.36M | 1.18% |
| Candriam Luxembourg S.C.A. | 584,272 | $3.18M | 0.02% |
| Acadian Asset Management LLC | 354,453 | $1.93M | 0.01% |
| Marshall Wace, LLP | 296,405 | $1.61M | 0.01% |
| Assenagon Asset Management S.A. | 115,785 | $631.0K | 0.00% |
| Engineers Gate Manager LP | 82,200 | $448.0K | 0.03% |
| Connor, Clark & Lunn Investment Management Ltd. | 76,052 | $414.0K | 0.00% |
| ACT Capital Management, LLC | 52,500 | $287.0K | 0.15% |
| Group One Trading, L.P. | 23,348 | $127.0K | 0.00% |
| Parametric Portfolio Associates LLC | 19,110 | $104.0K | 0.00% |
| Raymond James & Associates | 15,500 | $84.0K | 0.00% |
| Caas Capital Management LP | 13,905 | $76.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 13,049 | $71.0K | 0.01% |
| Fox Run Management, L.L.C. | 12,826 | $70.0K | 0.06% |
| Capital Advisory Group Advisory Services, LLC | 700 | $4.00K | 0.00% |
| West Oak Capital, LLC | 100 | $1.00K | 0.00% |
| Signaturefd, LLC | 171 | $1.00K | 0.00% |
| State of Wyoming | 216 | $1.00K | 0.00% |
Sold out (25)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.